Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
OIG Highlights Top 25 Unimplemented Recommendations
By Kelly A. Briganti, Editorial Director, G2 Intelligence The HHS Office of Inspector General (OIG) has issued its opinion on the top things the government isn’t doing that could generate cost savings and improve quality of HHS programs and thus should be an...
Urine Biomarker Test Promises Early Detection of Kidney Cancer
By Stephanie Murg, Managing Director, G2 Intelligence A noninvasive screening method may hold the promise of improved outcomes for patients with kidney cancer, which affects approximately 65,000 people each year in the United States. The key is early diagnosis: If...
MEDCAC Meeting Set for Molecular Pathology Testing
By Christopher P. Young, Editor, G2 Compliance Advisor The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) is meeting on March 24 to consider evidence about the prognostic capability of certain molecular pathology tests that may have...
Exact Sciences Lands Major Payer Coverage for Cologuard Test
By Ron Shinkman, Editor, Laboratory Industry Report Exact Sciences, the Wisconsin-based molecular laboratory, has added an impressive list of names to its roster that are providing some form of coverage or support to its colon cancer assay. Anthem, one of the...
Personal Genome Diagnostics, VA Partner for Precision Oncology Program
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Personal Genome Diagnostics' CancerSelect targeted gene profiling panel has been selected for use in all newly-diagnosed lung cancer patients in the U.S. Department of Veterans Affairs (VA) New...
At Lab Revolution Conference, a Peek Inside Quest’s ‘Lab of the Future’
By Stephanie Murg, Managing Director, G2 Intelligence What does the lab of the future look like? This question was addressed by a broad range of experts at G2 Intelligence’s Lab Revolution 2015 conference, held March 11-13 in Orlando, Florida. Among the speakers...